Why Is HIMS & HERS HEALTH I A (HIMS) Stock Down Today?
By the Top Tier Newswire AI Desk · August 28, 2026 at 2:01 PM ET · reviewed against 6 wire stories
HIMS & HERS HEALTH I A (HIMS) is down -9.19% in the latest session. Our newswire has captured 6 stories on HIMS across 5 sources in the last 36 hours, with AI sentiment reading mixed (avg 51/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
HIMS stock fell 9.19% to $28.75 on August 28, 2026, driven by a sharp intraday decline and a broader sell-off in the shares. The stock opened at $31.33, a 1.0% gap down from the previous close, and continued to fall throughout the session, hitting a low of $28.73. The move came amid recent regulatory scrutiny and a string of insider sales, as well as ongoing pressure from a weak earnings profile and a deteriorating sentiment trend.
What Happened
The CEO of Hims & Hers, Andrew Dudum, recently stated on CNBC that the Federal Trade Commission’s lawsuit against the company “misunderstands how the company works.” This comment followed allegations concerning the company’s data-sharing and subscription practices. Meanwhile, the company faces an ongoing investigation by Kaplan Fox for potential violations of federal securities laws. These developments appear to have heightened investor concerns about the company’s regulatory exposure. Additionally, Hims & Hers has seen a series of insider sales in recent days, including transactions by the CFO, general counsel, and chief policy officer. The stock has also been under pressure due to its unprofitable status, with a trailing twelve-month net margin of -5.5% and a beta of 2.42, making it more volatile than the broader market.
What The Data Shows
The stock’s intraday session showed a significant decline, with volume reaching 7.3 million shares, or 0.4 times the 3-month daily average. The stock hit a fresh 52-week low on the day, marking the 42nd such instance since the start of the year. Options activity was skewed toward calls, with $2.6 million in call premiums compared to $0 in puts. Over the last 30 days, sentiment has worsened, dropping from an average of 47 out of 100 to 43 out of 100. In the past 90 days, insiders have sold 11 times, totaling $7.2 million, with no insider buying reported.
What To Watch
The company has no upcoming earnings report scheduled. Investors should monitor the breadth of coverage and any further developments in the ongoing regulatory investigations or changes in sentiment.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
HIMS · Aug 28 session (5-min) · -8.78% vs prior close · updated 8:44 PM ETAI sentiment, last 36h · averaged over 6 stories · 51/100 neutral
The headlines behind the move
Story flow · 6 stories on the wire, last 36h · hover or tap a dot for the headline
15d agoYahoo TopNEUTRAL 46General
Hims & Hers (HIMS) CEO Says the FTC Doesn’t Understand His Own Company
On August 18, 2026, Hims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum told CNBC that a Federal Trade Commission lawsuit over the company’s data-sharing and subscription practices “misunderstands how the company works.” He defended the company’s compounded GLP-1 drug sales as having helped lower prices for weight-loss treatments. Why This Matters Hims & Hers […]
15d agoThe Motley FoolBULLISH 57Analyst
After Doubling in Six Months, Is it Too Late to Buy Hims & Hers Stock?
The healthcare industry is ripe for disruption.
15d agoBusiness InsiderBEARISH 34General
Kaplan Fox is Investigating Hims & Hers Health, Inc. (HIMS) for Potential Violations of the Federal Securities Laws
New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox Kilsheimer LLP is investigating...
15d agoYahoo TopBEARISH 42General
Hims & Hers (HIMS)’ Weight-Loss Plans Results Penalties Over Visa (V) Credit Card Disputes
16d agoSeeking AlphaBULLISH 67Product/PR
Hims & Hers Is Growing Into Something Much Bigger
Hims & Hers approaches 3 million subscribers as U.S. growth reaccelerates and international markets emerge as a meaningful second growth engine. Learn more about HIMS stock here.
16d agoThe FlyBULLISH 57General
Moderately bullish activity in Hims and Hers Health with shares up 3.74%
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →